Phone -
To monitor and define tumor-associated antigen expression and to develop TCR-engineered T cell therapy directed at these specific tumor-antigen targets for high risk AML patients to reduce relapse
To monitor and define tumor-associated antigen expression and to develop TCR-engineered T cell therapy directed at these specific tumor-antigen targets for high risk AML patients to reduce relapse